University of the Incarnate Word
San Antonio, TX 78209
Phone Number: (210) 283-5033
01/2014 University of Texas Health Science Center at San Antonio (UTHSCSA)
Ph.D. Biomedical Science – Department of Pharmacology
Thesis Title: Cannabinoid and peroxisome proliferator-activated receptors as anti-dyskinetic targets.
Thesis Advisor: Andrea Giuffrida, Ph.D.
05/2004 St. Mary’s University – San Antonio, Texas
08/2017-Present Assistant Professor (Tenure-Track), Biology Department, University of the Incarnate Word, San Antonio, TX
08/2013- 05/2017 Visiting Assistant Professor, Biology Department, Trinity University, San Antonio, TX
08/2012-05/2013 Adjunct Professor, Biology Department, St. Mary’s University, San Antonio, TX
01/2010-05/2010 Guest Lecturer, Dental Hygiene Pharmacotherapeutics Course, UTHSCSA
01/2009-05/2009 Part-time Instructor, Biology Department, Trinity University, San Antonio, Texas.
01/2009-05/2009 Guest Lecturer, Dental Hygiene Pharmacotherapeutics Course, UTHSCSA
03/2014- Present Postdoctoral Fellow, Department of Pharmacology, UTHSCSA, (Part-time)
10/2004-08/2007 Research Assistant, Pharmacology Dept., UTHSCSA, Laboratory of Dr. J. Roberts/Dr. A. Giuffrida
05/2015- 07/2017 Carla Carmona, Voelcker Academy Scholar, Robert E. Lee High School, San Antonio, TX
04/2011-05/2012 Mentored Jessica Briscoe, MBRS-RISE Program, University of Texas at San Antonio, San Antonio, TX
06/2010-08/2010 Mentored Michelle Yuan, Summer Research Intern, Bard College, Annandale-on-Hudson, NY
1F31NS073411-03, NIH/NINDS, 01/2011-12/2013
Ruth L. Kirschestein National Research Service Award Individual Fellowship
Project Title: Validation of PPARgamma Agonists as Anti-Dyskinetic Drugs
Role: PI Description: Despite L-DOPA initial beneficial effects in treating Parkinson’s disease, its prolonged use results in the development of abnormal involuntary movements known as dyskinesia. Recent evidence suggests that activation of the nuclear receptor, PPARgamma, ameliorates these unwanted side effects once they are fully established. This proposal investigated whether co-administration of L-DOPA and a PPARgamma agonist (rosiglitazone) prevents the development of dyskinesias in a rodent model of Parkinson’s disease.
03/2018-Present Coach/Volunteer, Catholic Youth Organization, Archdiocese of San Antonio
01/2018-Present Faculty Sponsor, UIW SACNAS Chapter, SACNAS Local Conference Committee
03/24/2018 Word in Action, UIW Day of Service, Time Dollar Community Connections
04/04/2017 8th Annual CORE4STEM Family Day, Exhibit Presenter, San Antonio College
2013 - Best Oral Presentation, 2013 Annual Terry Mikiten GSA Research Forum, UTHSCSA
2011 - Pharmacology Student of the Year, UTHSCSA
2010 - Third place poster, 2010 Annual Terry Mikiten GSA Research Forum, UTHSCSA
2010 - Pharmacology Graduate Student Symposium Chairman, UTHSCSA
2009 - Pharmacology Graduate Student Symposium Co-Chairman, UTHSCS
2008 - Pharmacology Graduate Student Symposium Committee, UTHSCSA
2000 - 2004 Presidential Scholarship, St. Mary's University, San Antonio, TX.
2007 - Present Society for Neuroscience (SFN)
2007 - Present Center for Biomedical Neuroscience, UT Health San Antonio
2007 - 2012 Student member of the San Antonio Chapter of the SFN
2010 - Student member of the International Behavioral Neuroscience Society (IBNS)
1. Giuffrida A and Martinez AA. The Endocannabinoid System and Parkinson's Disease. In: The Endocannabinoid System: Genetics, Biochemistry, Brain Disorders, and Therapy. (E. Murillo-Rodriguez, ed). Elsevier, Pp 63-81 (2017).
2. Giuffrida A and Martinez AA. Cannabinoids and levodopa-induced dyskinesia. In: Levodopa-induced Dyskinesia in Parkinson's Disease (S. Fox, J. Brotchie, eds.). Springer, Pp 245-264 (2014).